Novartis to skip loans for Alcon acquisition
Loans bankers on Monday played down the chances of Novartis, the Swiss pharmaceutical firm which needs to raise $16bn to fund its $38.5bn takeover bid for Alcon, launching a jumbo loan. It will probably issue bonds instead, they said.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
